Loxo Oncology (LOXO) Reports Q3 Loss of $0.82/Share

November 2, 2016 6:46 AM EDT
Get Alerts LOXO Hot Sheet
Trade LOXO Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Loxo Oncology (NASDAQ: LOXO) reported Q3 EPS of ($0.82), versus ($0.53) reported last year.

For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment